Dal Cason, TA. An evaluation of the potential for clandestine manufacture of 3,4-methylenedioxyamphetamine (MDA) analogs and homologs. J. Forensic Sci., 1 May 1990, 35 (3), 675–697. 2.2 MB. https://doi.org/10.1520/JFS12874J
Świst, M; Wilamowski, J; Zuba, D; Kochana, J; Parczewski, A. Determination of synthesis route of 1-(3,4-methylenedioxyphenyl)-2-propanone (MDP-2-P) based on impurity profiles of MDMA. Forensic Sci. Int., 10 May 2005, 149 (2–3), 181–192. 594 kB. https://doi.org/10.1016/j.forsciint.2004.06.016 #T2-9 MS
Shulgin, AT. The separation and identification of the components of the aromatic ether fraction of essential oils by gas-liquid chromatography. J. Chromatogr. A, 1 Jan 1967, 30, 54–61. 769 kB. https://doi.org/10.1016/S0021-9673(00)84112-6 #IVc GC
Shulgin, AT. The narcotic pepper — The chemistry and pharmacology of Piper methysticum and related species. Bull. Narc., 1 Jan 1973, 25 (2), 61–77. 325 kB. #XII UNODC.
Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.
Noggle, FT; Clark, CR; DeRuiter, J. Gas chromatographic and mass spectrometric analysis of samples from a clandestine laboratory involved in the synthesis of ecstacy from sassafras oil. J. Chromatogr. Sci., 1 Apr 1991, 29 (4), 168–173. 1.1 MB. https://doi.org/10.1093/chromsci/29.4.168 #Isosafrole GC,MS
Sorokin, V; Beljaev, A; Ponkratov, K. Expert examination of MDA. JCLIC, 1 Jul 1993, 3 (3), 13-15. 556 kB. IR
Nair, JB; Hakes, L; Yazar-Klosinski, B; Paisner, K. Fully validated, multi-kilogram cGMP synthesis of MDMA. ACS Omega, 11 Jan 2022, 7 (1), 900–907. 2.6 MB. https://doi.org/10.1021/acsomega.1c05520 #9